Note 1 - Nature of the Business and the Basis of Preparation - Schedule of Subsidiaries (Details) |
Sep. 30, 2026 |
|---|---|
| BeyondSpring U.S. [Member] | |
| Percentage of ownership by the Group | 100.00% |
| BeyondSpring Pharmaceuticals Australia PTY Ltd. (“BeyondSpring Australia”) [Member] | |
| Percentage of ownership by the Group | 100.00% |
| BVI Biotech [Member] | |
| Percentage of ownership by the Group | 100.00% |